Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels by Danae Campos-Melo et al.
Campos-Melo et al. Molecular Brain 2013, 6:26
http://www.molecularbrain.com/content/6/1/26RESEARCH Open AccessAltered microRNA expression profile in
amyotrophic lateral sclerosis: a role in the
regulation of NFL mRNA levels
Danae Campos-Melo1, Cristian A Droppelmann1, Zhongping He1, Kathryn Volkening1,3 and Michael J Strong1,2,3,4*Abstract
Background: Amyotrophic Lateral Sclerosis (ALS) is a progressive, adult onset, fatal neurodegenerative disease of
motor neurons. There is emerging evidence that alterations in RNA metabolism may be critical in the pathogenesis of
ALS. MicroRNAs (miRNAs) are small non-coding RNAs that are key determinants of mRNA stability. Considering that
miRNAs are increasingly being recognized as having a role in a variety of neurodegenerative diseases, we decided to
characterize the miRNA expression profile in spinal cord (SC) tissue in sporadic ALS (sALS) and controls. Furthermore,
we performed functional analysis to identify a group of dysregulated miRNAs that could be responsible for the
selective suppression of low molecular weight neurofilament (NFL) mRNA observed in ALS.
Results: Using TaqMan arrays we analyzed 664 miRNAs and found that a large number of miRNAs are differentially
expressed in ventral lumbar SC in sALS compared to controls. We observed that the majority of dysregulated miRNAs are
down-regulated in sALS SC tissues. Ingenuity Pathway Analysis (IPA) showed that dysregulated miRNAs are linked with
nervous system function and cell death. We used two prediction algorithms to develop a panel of miRNAs that have
recognition elements within the human NFL mRNA 3′UTR, and then we performed functional analysis for these miRNAs.
Our results demonstrate that three miRNAs that are dysregulated in sALS (miR-146a*, miR-524-5p and miR-582-3p) are
capable of interacting with NFL mRNA 3′UTR in a manner that is consistent with the suppressed steady state mRNA levels
observed in spinal motor neurons in ALS.
Conclusions: The miRNA expression profile is broadly altered in the SC in sALS. Amongst these is a group of
dysregulated miRNAs directly regulate the NFL mRNA 3′UTR, suggesting a role in the selective suppression of NFL mRNA
in the ALS spinal motor neuron neurofilamentous aggregate formation.
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Amyotrophic lateral sclerosis (ALS) is a progressive, age-
dependent, fatal disorder in which motor neurons within
the brain and spinal cord (SC) degenerate. While the
majority of cases are sporadic (sALS), 5 – 10% are famil-
ial (fALS) and include genes mediating a seemingly di-
verse number of processes. These include mutations in
genes encoding Cu/Zn superoxide dismutase 1 SOD1;
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distribution, and reproduction in any mediumbinding protein 43 kDa or TDP-43; [4-6] , FUS/TLS en-
coding a RNA processing protein fused in sarcoma/
translocated in liposarcoma; [7,8] and an expanded
hexanucleotide repeat in the non-coding region of
C9ORF72 [9,10]. The pathology and alterations in ex-
pression of RNA binding proteins such as mutant SOD1
(mtSOD1), TDP-43 and FUS/TLS in ALS, as well as evi-
dence of mutations in these proteins being associated
with altered RNA processing, has suggested that alter-
ations in the metabolism of RNA may be critical to the
pathogenesis of ALS [1,6,8,11].
In addition, several of the proteins associated with ALS
have the capacity to regulate the stability of the low mo-
lecular weight neurofilament (NFL) mRNA [12], of which
the steady state levels are selectively suppressed in sALSentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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NFL mRNA [16] and TDP-43 that stabilizes NFL mRNA
[17]. We have also recently described a novel RNA bind-
ing protein, RGNEF (Rho guanine nucleotide exchange
factor) that acts as NFL mRNA destabilizing factor and
forms protein aggregates in ALS [18]. While the net effect
of the coordinated action of these RNA binding proteins
on NFL mRNA stability in vivo remains to be clarified, it
is of interest that both NFL mRNA and TDP-43 are differ-
entially partitioned to degradative granules (P-bodies) in
ALS affected lumbar spinal motor neurons [12]. This is in
contrast to the physiological partitioning of TDP-43 to
stress granules observed following axonal injury [19,20].
Both stress granules and P-bodies exist in a constant state
of dynamic flux, mediated by the nature of associated
microRNAs miRNAs; [21,22].
MiRNAs are highly-abundant, highly-conserved small
endogenous non-coding RNAs that participate in mRNA
stability and translational regulation by either promoting
degradation of mRNA, or by blocking translation without
degradation [23]. Accumulating evidence supports a key
role for miRNAs in all aspects of neuronal development,
function and plasticity [24-28]. While a role for altered
miRNA expression in a variety of neurodegenerative dis-
eases is increasingly being recognized [29-35], nothing is
known with respect to the miRNA expression profile in
spinal cord (SC) in ALS and the role of miRNAs on NFL
mRNA stability.
Here we used the quantitative RT-PCR based array
method (TaqMan array) to investigate the profile of
miRNA expression in ALS SC. Our results show significant
differences in the expression of a large group of miRNAs
in ALS SC lysates compared to controls. Among them is a
population of miRNAs that have miRNA recognition ele-
ments (MREs) within the human NFL mRNA 3′UTR
which we confirmed using functional analysis. Our data
suggest a potential role of miR-146a*, miR-524-5p and
miR-582-3p in the selective decrease of NFL mRNA ob-
served in ALS that could contribute to the etiology of
neurofilamentous aggregates and the pathology of ALS.
Results
sALS spinal cord has a characteristic miRNA expression
profile
To characterize the expression pattern of known human
miRNAs in sALS SC, RT-qPCR was performed using the
TaqMan Low Density Human MicroRNA assay kit as
described in the methods below. This allowed for the
analysis of a total of 664 miRNAs from 3 cases of con-
trols and 5 cases of sALS.
We observed 4 miRNAs expressed exclusively in sALS
but not in controls [miR-558 (p < 0.001); miR-16-2*, miR-
146a* (p < 0.01); miR-508-5p (p < 0.05)] (Table 1). In
addition, 7 miRNAs were expressed in controls and not insALS [miR-624 (p < 0.001); miR-520e, miR-524-5p, miR-
548a-5p, miR-606, miR-612, miR-647(p < 0.05)] (Table 2).
From 245 miRNAs expressed in both sALS and controls
but at statistically different levels, 6 were expressed in
sALS at higher levels than controls [miR-373*, miR-551a
(p < 0.01); miR-506, miR-518a-5p, miR-518e*, and miR-
890 (p < 0.05)] (Table 3) and all the remaining (239) were
down-regulated in the sALS SC tissue (Additional file 1:
Table S1). Only 10 miRNAs of the potential 664 miRNAs
had no expression in sALS or control lumbar SC
(Additional file 1: Table S2). To validate these observa-
tions, we randomly selected miRNAs from the results of
the TaqMan array and subjected these to RT-qPCR using
SYBR Green. We confirmed the significant alteration of
these miRNAs in the SC in sALS (data not shown).
These results demonstrate that a significantly altered
miRNA expression profile exists in the SC in sALS.
Dysregulated miRNAs in sALS are linked with nervous
system function and cell death
To identify networks and biological functions related to
the target genes of miRNAs differentially expressed in
sALS versus controls, we used Ingenuity Pathway Analysis
(IPA). A group of 256 miRNAs were analyzed. From these,
10 miRNAs were up-regulated in the SC in sALS (4
miRNAs expressed only in sALS and 6 miRNAs expressed
in both sALS and controls but at higher levels in sALS)
and all the remaining were down-regulated (7 miRNAs
expressed only in controls and 239 miRNAs expressed in
both sALS and controls but at higher levels in controls).
The most enriched associated networks and biological
functions amongst targets of dysregulated miRNAs are









Table 4 Top networks and biological functions of miRNAs
dysregulated in sALS
Top network functions for predicted targets of miRNAs up-
regulated in sALS
Associated network functions Score
Cellular development, nervous system
development and function, tissue development
3
Cellular assembly and organization, lipid
metabolism, nucleic acid metabolism
2
























Cell to cell signaling and interaction 2.92E-03-
2.92E-03
1
Physiological system development and
function





Immune cell trafficking 2.92E-03-
2.92E-03
1
Top network functions for predicted targets of miRNAs down-
regulated in sALS
Associated network functions Score
Cancer, gastrointestinal disease, hepatic system
disease
26
Cancer, reproductive system disease,
connective tissue disorders
24
Cell death, cancer, cell cycle 18
Cancer, reproductive system disease,
gastrointestinal disease
18
Reproductive system disease, cancer, cellular
growth and proliferation
11





Reproductive system disease 4.31E-88-
2.58E-03
93
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associated with nervous system development and function.
In addition, we identified inflammatory response within
the top biological functions of the predicted targets of
these miRNAs. As well, within the top network and bio-
logical functions of predicted targets of down-regulated
miRNAs in sALS we found cell death, cellular growth and
proliferation, inflammatory disease and nervous system de-
velopment and function (Table 4).
These results indicate that miRNAs dysregulated in
sALS could potentially be involved in the biological
functions affected in the ALS pathology.
MiRNAs differentially expressed in sALS have MREs in the
human NFL mRNA 3′UTR
We used two computational algorithms (microRNA.org,
TargetScan) to develop a predicted panel of miRNAs
that have differential expression in sALS and MREs
within the human NFL mRNA 3′UTR (Table 5). This
focus on NFL mRNA was driven by our previous obser-
vations of a selective suppression of NFL mRNA in
spinal motor neurons in ALS [13-15]. For predicting
MREs we considered the three NFL 3′UTRs reported:
NFL 3′UTR-Short (−S; 286 b), NFL 3′UTR-Medium
(−M; 1380 b) and NFL 3′UTR-Long (−L; 1838 b). We
took into account only miRNAs with perfect pairing of
their seed regions to their respective MREs within the
NFL 3′UTR, and either conserved or not conserved
MREs but always with good mirSVR scores and the most
favorable Gibbs free energies (ΔGs) required for the
interaction.
Using the above restrictions, the only miRNA that had
an MRE in the NFL mRNA 3′UTR and was up-
regulated in sALS was miR-146a*. All miRNAs down-
regulated in sALS had only one recognition element
within the NFL mRNA 3′UTR. Although the sequence
identity between NFL mRNA 3′UTRs among Homo sa-
piens and other mammals is over 90% (Figure 1A), we
found that some miRNA recognition sites are conserved
but others are not (Table 5). It is important to note that
some miRNAs have MREs within the three NFL 3′UTRs
reported, -S, -M and –L (e.g. miR-23a), others within
NFL 3′UTR-M and –L (e.g. miR-146a*) and one miRNA
Table 4 Top networks and biological functions of miRNAs


































Connective tissue development and function 2.16E-05-
2.16E-05
4
Hair and skin development and function 8.96E-03-
8.96E-03
1
Nervous system development and function 8.96E-03-
8.96E-03
1
Respiratory system development and function 8.96E-03-
3.54E-02
3
Table 5 MiRNAs differentially expressed in sALS and
controls, and predicted recognition elements (MRE) in
NFL 3′UTR







23a down S/M/L Conserved
23b down S/M/L Conserved
30a down S/M/L Conserved
30b down S/M/L Conserved
146a* up M/L Not conserved
192 down M/L Conserved
193a-
5p
down M/L Not conserved
215 down M/L Conserved
524-5p down L Not conserved
556-5p down M/L Not conserved
582-3p down S/M/L Not conserved
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L (miR-524-5p; Table 5, Figure 1B).
These results show that not only is the miRNA expres-
sion profile altered in ALS, but that miRNA that are pre-
dicted to target NFL mRNA 3′UTR are amongst those
that are altered.
MiRNAs differentially expressed in sALS regulate the
expression of a reporter coupled to NFL mRNA 3′UTR
To study the functional relevance of those miRNA with
altered expression in sALS on the regulation of the NFL
mRNA 3′UTR, we used luciferase reporter gene assays
and relative quantitative RT-PCR. We chose to examine
all three lengths of 3′UTR to provide information about
the availability of MREs to interact in the context of dis-
tinct mRNA structures. We transfected HEK293T cells
with pre-miRNAs and a reporter vector harboring one
of the three human NFL mRNA 3′UTR (−S, -M or -L).
In the reporter assay, we focused on two patterns:
miRNAs up-regulated in sALS that induced down-
regulation of the firefly luciferase activity, and miRNAsdown-regulated in sALS that induced up-regulation of the
luciferase activity. Both cases could explain the selective
suppression of NFL mRNA observed in the SC in sALS.
Reporter gene assays showed that the activity of firefly
luciferase was significantly decreased with miR-146a* (p <
0.001; up-regulated in sALS; Table 1) when the reporter
gene was bound to NFL mRNA 3′UTR-M (Figure 2).
Interestingly, this down-regulatory effect was not seen in
the case of miR-146a* on the reporter containing the NFL
3′UTR-L. In contrast, miR-23a, miR-23b and miR-30b
(down-regulated in sALS; Additional file 1: Table S1) in-
duced an increase of the luciferase activity when the re-
porter was linked only to NFL 3′UTR-S (p < 0.001;
Figure 2). In addition, miR-193a-5p and miR-556-5p were
also down-regulated in sALS (Additional file 1: Table S1)
and showed an up-regulatory effect on the NFL 3′UTR-
M (p < 0.001) and -L (p < 0.001 and p < 0.01, respectively;
Figure 2). Finally, miR-524-5p and miR-582-3p (down-
regulated in sALS; Table 2 and Additional file 1: Table S1)
induced an up-regulatory effect on the NFL 3′UTR-L
(p < 0.001), and NFL 3′UTR-S (p < 0.001), -M (p < 0.001)
and –L (p < 0.01; Figure 2), respectively. MiR-30c, miR-
192 and miR-215 did not show correlation between the
results of the reporter gene assay and the expression
levels observed in sALS that could explain the suppres-
sion of NFL mRNA observed in sALS SC (data not
shown). No relative change in the levels of the reporter
linked to the NFL 3′UTR was found in cells transfected
with miR-let-7a (negative control; Figure 2).
To elucidate whether the group of functional miRNAs
were acting on NFL mRNA stability or translational regu-
lation, we studied changes on the luciferase mRNA levels
caused by NFL 3′UTR regulation through miRNAs. Rela-
tive quantitative RT-PCR showed that miR-146a* was able
Figure 1 Illustration of the sequence alignment of the NFL mRNA 3′UTRs of different species. (A) Percentages of sequence identity
between Homo sapiens and other mammals are indicated. (B) MREs within the different NFL mRNA 30 UTRs. Note that not all miRNAs have MREs
within the three NFL 3′UTRs reported (−S, -M and –L).
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NFL 3′UTR-M (p < 0.01; Figure 3), while miR-524-5p and
582-3p were able to increase the level of luciferase mRNA
coupled to NFL 3′UTR-L (p < 0.01) and NFL 3′UTR-S
(p < 0.001), -M (p < 0.001) and –L (p < 0.001), respectively
(Figure 3). The remaining miRNAs are not presented be-
cause they did not show significant differences in the RT-
PCR, or showed RT-PCR results in disagreement with the
reporter gene assay that could be explained by an add-
itional miRNA effect (direct or indirect) on translation
(data not shown).
Therefore, miR-146a*, miR-524-5p and miR-582-3p
showed consistent results in the reporter gene assay and
the relative quantitative RT-PCR, making them prime
candidates for the negative regulation of NFL mRNA ex-
pression in the SC in ALS.
MiR-146a*, miR-524-5p and miR-582-3p directly regulate
NFL expression
To study whether the regulatory effect of miR-146a*,
miR-524-5p and miR-582-3p on the NFL 3′UTR was
direct or indirect, we developed 3′UTR mutants of each
MRE to test them with the reporter gene assay. Wemutated only the first two nucleotides of the 3′ end of
each miRNA recognition element thereby preventing
broad changes in the NFL 3′UTR secondary structure
that could interfere with the interpretation of our results
(Figure 4A). Previously, it has been reported that mis-
matches at these positions significantly reduced the
magnitude of target regulation [36]. In fact, two muta-
tions within any of the three MREs analyzed (miR-146a*,
miR-524-5p and miR-582-3p) further destabilized target
recognition, yielding less favorable ΔGs (Figure 4B).
The reporter gene assay showed that all NFL 3′UTR
MRE mutants exhibited a significant decrease in the ef-
fect of each miRNA compared with the wild type. Our
data demonstrate that miR-146a*, miR-524-5p and miR-
582-3p are able to directly regulate the NFL 3′UTR
(Figure 4C).
All of our results demonstrate that a pool of three
functionally relevant miRNAs capable of interacting with
NFL mRNA 3′UTR, miR-146a*, miR-524-5p and miR-
582-3p, are dysregulated in sALS, suggesting their par-
ticipation in the regulation of NFL mRNA expression in
mammalian cells. It is interesting to note that not all the
miRNA found to be expressed at different levels in sALS
Figure 2 (See legend on next page.)
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Figure 2 A pool of miRNAs dysregulated in sALS regulates the activity of a reporter linked to NFL 3′UTR. Reporter gene assay was
performed transfecting HEK293T cells with pre-miRNAs and a reporter construct expressing firefly luciferase coupled to NFL 3′UTR-S (white bar), -M
(grey bar) or -L (black bar). The results of firefly luciferase activity were normalized with Renilla reporter luciferase activity and with the effect of each
miRNA on the luciferase mRNA alone (pmirGLO vector control). Data are expressed as relative change and show positive values as up-regulation and
negative values as down-regulation. Experiments were performed in triplicate. Result are shown as mean ± SEM (t-test: *** = p < 0.001; ** = p < 0.01,
relative to the pmirGLO vector control). Note that not all miRNA have predicted interaction sites in all lengths of NFL 3′UTR, only data for which a
predicted site is present are shown. In addition, only miRNAs with correlation among the results of the reporter gene assay and the expression
observed in sALS are presented.
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to the NFL mRNA 3′UTR. These data strongly suggest
that it will likely be a net effect of action of all miRNA
involved in NFL expression, and not the action of one
single miRNA, that is important for NFL regulation.
Discussion
This study is the first comprehensive examination of the
miRNA expression profile of SC tissue in ALS. We ob-
served that the majority of dysregulated miRNAs in sALS
(256) are down-regulated (246) and only a small group are
up-regulated (10). This is the first report of a massive
miRNA decrease compared with other neurodegenerative
diseases [37-40]. Amongst those miRNAs that we ob-
served to be differentially expressed in ventral lumbar SC
in sALS compared to controls, we identified a panel of
miRNAs with MREs in the human NFL mRNA 3′UTR
that were able to regulate the expression of a luciferase re-
porter bearing this 3′UTR in mammalian cells.
We previously observed that RNA species could con-
tribute to NFL mRNA stability in a series of in vitro ex-
periments in which we incubated biotinylated humanFigure 3 MiR-146a*, miR-524-5p and miR-582-3p regulate the express
after the co-transfection of HEK293T cells with pre-miRNAs whose function was
construct expressing firefly luciferase coupled to NFL 3′UTR-S (white bar), -M (gr
luciferase, the impact of each miRNA on the luciferase mRNA without NFL 3′UT
the luciferase mRNA to obtain the specific effect on the NFL mRNA 3′UTR. Data
positive values and down-regulation as negative values. Experiments were perfo
** = p < 0.01, relative to the pmirGLO vector control). Note that only results for t
gene assay data are presented.NFL mRNA with SC homogenates from control, sALS,
mtSOD1-associated familial ALS (fALS), and non-
mtSOD1 fALS and then assayed NFL mRNA levels [12].
Pretreatment of the SC homogenates with RNAse resulted
in a significant increase in NFL mRNA stability, suggesting
a role for RNA species that destabilizes NFL mRNA in
ALS. Considering that miRNAs are key mRNA stability de-
terminants, they presented a likely candidate to explain our
previous results. To address this, we restricted our analysis
to the lumbar SC given our longstanding interest in defin-
ing the mechanisms related to alterations in NFL mRNA
stability associated with intraneuronal neurofilament ag-
gregate formation in lumbar spinal motor neurons in ALS
[41]. Moreover, we have also previously shown that alter-
ations in NFL mRNA steady state levels observed in spinal
motor neurons in ALS by in situ hybridization [15] could
also be observed in ventral spinal cord tissue homogenates,
but not in dorsal spinal cord homogenates or in tissues
outside of the SC [42].
Of the group of miRNAs dysregulated in sALS SC that
have MREs in the NFL 3′UTR, we found a significant
increase in the expression of miR-146a*. This increaseion of NFL mRNA 3′UTR. Relative quantitative RT-PCR was performed
correlated with the differential expression observed sALS and a reporter
ey bar) or -L (black bar). Firefly luciferase was normalized to Renilla
R (pmirGLO vector control), and the effect of miR-let-7a (miRNA control) on
are expressed as relative mRNA level change and show up-regulation as
rmed in triplicate. Result are shown as mean ± SEM (t-test: *** = p < 0.001;
hose miRNAs that showed RT-PCR results in agreement with the reporter
Figure 4 (See legend on next page.)
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Figure 4 Mutations in the recognition elements of miR-146a*, miR-524-5p and miR-582-3p reveal a direct regulation of the miRNA on
luciferase transcripts coupled to the NFL 3′UTR. (A) Mutants of MREs within the NFL 3′UTR. Only the first two nucleotides of the 3′ end of
each MRE were mutated (arrows) preventing broad changes in the NFL 3′UTR secondary structure. (B) ΔGs of wild type (WT) and mutant (Mut)
MREs within NFL 3′UTR. (C) Reporter gene assay performed with mutant NFL 3′UTRs. The results of firefly luciferase activity were normalized with
Renilla reporter luciferase activity and the effect of each miRNA on the luciferase mRNA alone (pmirGLO vector control). Data are expressed as
relative change and show up-regulation as positive values and down-regulation as negative values. Experiments were performed in triplicate.
Result are shown as mean ± SEM (t-test: *** = p < 0.001; * = p < 0.05, relative to the pmirGLO vector control). All the NFL 3′UTR mutants showed a
significant decrease in the effect of each miRNA compared with the wild type.
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seen in ALS, given that this miRNA directly down-
regulates the expression of a reporter linked to the NFL
mRNA 3′UTR. Interestingly, miR-146a* strongly down-
regulated the reporter coupled to NFL 3′ UTR-M but
not when coupled to NFL 3′UTR-L. This result suggests
that varying the length of the 3′UTR may alter the
mRNA structure sufficiently to allow or disallow the
interaction of miRNAs or other interactors such as RNA
binding proteins, introducing another level of complex-
ity to the regulation of NFL mRNA stability.
MiRNAs are thought to have predominantly a silencing
effect on their targets. Although less common, miRNAs can
also have either direct or indirect up-regulatory effects on
mRNA expression. For example, miR-34 can interact with
β-actin 3′UTR and positively regulating its expression [43],
while miR-466 l up-regulates IL-10 mRNA expression in
TLR-triggered macrophages by antagonizing RNA-binding
protein tristetraprolin-mediated IL-10 mRNA degradation
[44]. In our studies, we observed that two miRNAs whose
expression levels were down-regulated in sALS (miR-524-
5p and miR-582-3p) induced an increase of the reporter
linked to the NFL mRNA 3′UTR. This reduced expression
of miRNAs that can up-regulate NFL (such as miR-524-5p
and miR582-3p) further supports our previous observations
that NFL mRNA is selectively decreased in ALS.
Many recognition sites in the NFL mRNA 3′UTR for
miRNAs dysregulated in sALS are conserved among differ-
ent species. However, we have to consider that non-
conserved sites can be as important, and can occur as fre-
quently as conserved sites [45,46]. For example, almost half
of all validated miRNA binding sites in the p21 mRNA 3′
UTR were not evolutionarily conserved [47], indicating that
exclusive attention to only conserved sites could bias against
other important interactions. It is interesting that miR-146a
*, miR-524-5p and miR-582-3p sites in the NFL mRNA 3′
UTR are not conserved across species and all of them
showed consistent results making them prime candidates
for the down-regulation of NFL mRNA expression in the
SC in ALS. This strongly suggests that these sites may be of
importance, particularly in humans, for NFL regulation.
Of the three miRNAs that we showed could be involved
in the selective decrease of NFL mRNA observed in ALS
SC, miR-582-3p has been previously reported to have apossible role in the negative regulation of Smad3, one of
the intracellular mediators of TGF-β. As TGF-β mediates
apoptosis, down-regulation of miR-582-3p could addition-
ally promote cell death [48]. This observation is in agree-
ment with the IPA that showed that miRNAs differentially
expressed in sALS SC are in general linked with cell death.
The complexity of the process is also highlighted by the
observation that miRNAs can act singly or coordinately.
We have experimentally confirmed that several miRNAs
can regulate a reporter linked to NFL mRNA 3′UTR. This
suggests that it may be the combination of expression and
the cumulative effects of a group of miRNAs that are more
important to overall regulation than the expression of any
single miRNA. As well, the interaction of RNA binding
proteins with NFL mRNA could alter the folded structure
of the mRNA and as a result, alter miRNA access to their
respective binding sites. Further defining the impact of se-
questering RNA binding proteins in aggregates, which are
commonly found in degenerating motor neurons in ALS,
will be an imperative subject for future investigation.
Taken together, this points to a complex regulatory system
involving miRNA, which must be examined in the context
of all regulatory elements (trans and cis) that may affect a
single mRNA.
Conclusions
This study provides the first evidence that the miRNA
expression profile is broadly altered in the SC in sALS.
Among miRNAs dysregulated in sALS, there is a group
of (miR-146a*, 524-5p and 582-3p) that directly regulate
the NFL mRNA 3′UTR, suggesting an involvement in
the selective suppression of NFL mRNA in the spinal
motor neurons in ALS.
Methods
Tissues
We selected 3 cases of non-neurological disease controls
and 5 cases of sALS (Table 6). All ALS cases were both clin-
ically and neuropathologically confirmed using the El Escor-
ial Criteria (World Federation of Neurology Research Group
on Neuromuscular Disease, 1994). Written consent for tis-
sue donation at autopsy was obtained from either the pa-
tient (ante-mortem) or the spouse (post-mortem) in
accordance with the London Health Sciences Centre ethics
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known mutations in SOD1,TARDBP, FUS/TLS or expanded
repeats on C9ORF72 by Dr. Rosa Rademakers (Mayo Clinic,
Jacksonville, Florida). No cases were associated with cogni-
tive impairment or frontotemporal degeneration.MiRNA extraction
MiRNAs were extracted using the mirVana™ miRNA isola-
tion kit (Life Technologies Inc., Ambion, Burlington, ON,
Canada) according to the manufacturer’s instructions.
Briefly, archival ventral lumbar SC tissue stored at −80°C
was placed in 10 volumes of lysis/binding buffer on ice
and homogenized with a Polytron until all visible clumps
were dispersed. After organic extraction with acid-phenol:
chloroform, miRNA isolation was performed by precipi-
tating with ethanol and purifying over two consecutive
glass-fiber filters. This procedure yielded a size-selected
RNA fraction consisting of RNA species of less than 200
bases. Yield and purity of the miRNA enriched fraction
was measured by UV absorbance at OD260/280. Quality
of RNA samples was confirmed by BioAnalyzer (Agilent).MiRNA real-time qRT-PCR
The stem-loop RT-PCR based TaqMan Human MicroRNA
Arrays (Life Technologies Inc., Applied Biosystems,
Burlington, ON, Canada) were used representing 664 ma-
ture miRNA in the Sanger miRBase v12 in a two-card set
of arrays (Array A and B). Array A contained 3 positive
controls and 1 negative control while Array B contained 6
positive controls and 1 negative control. RT-PCR reactions
were performed according to the manufacturer’s instruc-
tions. Briefly, 300 ng of enriched miRNA (extracted as de-
scribed above) was reverse transcribed using Megaplex RT
Primers and the TaqMan miRNA reverse transcription kit
(Life Technologies Inc., Applied Biosystems). For pre-
amplification of miRNA cDNA, the RT product was pre-
amplified using Megaplex PreAmp Primers and TaqMan
PreAmp Master Mix as per manufacturer’s protocols (Life
Technologies Inc., Applied Biosystems). The pre-amplified
cDNA was diluted with 0.1 × TE (pH 8.0) to 100 μl andTable 6 Patient demographics for SC tissues included in this
Case Gender Age at symtom onset (yrs) Age at death (yrs
Control F - 53
Control M - 68
Control F - 62
ALS F 47 49
ALS F Unknown 41
ALS M 55 61
ALS M 40 44
ALS M 64 67
-: Not applicable.then 10 μl of the cDNA was used in each plate for RT-
qPCR reaction.
Quantitative real-time PCR (RT-qPCR) was performed
using the Applied Biosystems 7900HT system and TaqMan
Universal Master Mix (Life Technologies Inc., Applied
Biosystems). Cycle threshold (Ct) values were calculated
using the SDS software v.2.3. Ct values > 40 were consid-
ered to be below the detection level of the assay, therefore,
only the miRNAs with Ct ≤ 40 were included in the
analyses.
For the data analysis the Ct value of the endogenous
mammalian U6 control was subtracted from the corre-
sponding Ct value for the target gene resulting in the
normalized ΔCt value. The Student’s t test was used to
determine significant differences among ΔCt values of
control and sALS groups. The differential expression (the
difference between the average of normalized ΔCt value
of the target sample (sALS) and the average of normal-
ized ΔCt value for the corresponding calibrator sample
(control); ΔΔCT), was used to calculate the expression
fold value as follows:
Log10RQ ¼ Log102−Δ ΔCTð Þ
Where Log10RQ correlates directly with up- (positive
value) and down-regulation (negative value).
For control cases, the results were deemed negative if
all cases were negative for expression. For sALS cases,
agreement amongst 4 or more cases was required to
consider the result either positive or negative.
Analysis of miRNA target genes
We used Ingenuity Pathway Analysis (IPA, 368 Ingenuity®
Systems, Redwood City, CA) to analyze dysregulated
miRNAs in the SC in ALS. IPA allows us to identify over-
represented networks and biological functions of miRNA
target genes. The networks are scored with a numerical
value and a score ≥ 2 was considered significant. The score
is based on the number of Network Eligible molecules in
the network, the size of the network, the Network Eligible
molecules in the given dataset and the number ofstudy
) Symptom onset Cause of death
- Cardiac transplant, pneumonia, rejection
- Cancer





Upper limb, weakness Respiratory failure
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cluded in the network. The p-value associated with a bio-
logical process is calculated with the Fisher’s exact test,
considering the number of functions/pathways/lists of eli-
gible molecules that participate in the annotation, the total
number of knowledge base molecules known to be associ-
ated with that function, the total number of functions/
pathways/lists eligible molecules and the total number of
genes in the Reference Set (IPA tutorial).
MiRNA target prediction
To determine if miRNAs differentially expressed in
sALS have miRNA recognition elements within the
NFL mRNA 3′UTR we used two miRNA target pre-
diction sites: microRNA.org (http://www.microrna.
org/microrna/getGeneForm.do) [49] and TargetScan
(http://www.targetscan.org/) [45].
Plasmid construction
Three reporter plasmids were constructed by inserting hu-
man NFL 3′UTR of different lengths between NheI and
SalI sites downstream of the firefly luciferase gene in the
pmirGLO vector (Promega, Madison, WI, USA; pmirGLO-
NFL 3′UTR). NFL 3′UTR-Short (−S) encoded the shortest
predicted isoform homologous to the murine NFL mRNA
(GenBank NM_010910) consisting of 1–286 b of the 3′
UTR. NFL 3′UTR-Medium (−M) included bases 1–1380
(GenBank BC039237), and NFL 3′UTR-Long (−L) com-
prised bases 1–1838 (GenBank NM_006158). Mutations in
two nucleotides of each MRE of the NFL 3′UTR were in-
troduced using QuikChange Lightning Site-Directed Muta-
genesis kit (Agilent Technologies Canada Inc., Mississauga,
ON, Canada) according to the manufacturer’s instructions.
Mutagenesis was designed carefully preventing broad
changes in the NFL 3′UTR secondary structure using the
mfold web server (http://mfold.rit.albany.edu/?q=mfold/
RNA-Folding-Form) [50]. ΔG values for the interaction
among each miRNA and MREs were calculated using
RNAhybrid server [51].
Cell culture and transfection
To perform functional analysis, HEK293T cells were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% FBS and plated 24 h prior to
transfection in 96-well plates at 9 × 103 cells/well. Cells
were co-transfected with 100 nM of pre-miRNAs (Life
Technologies Inc., Ambion) and 3.47 fmol of pmirGLO-
NFL 3′UTR (−S, -M or -L) using Lipofectamine 2000 re-
agent (Life Technologies Inc., Invitrogen, Burlington, ON,
Canada), according to the manufacturer’s instructions.
Luciferase reporter assay
Luciferase activity was measured 24 h after transfection
using the Dual-Glo Luciferase Assay System (Promega)in a Luminometer (Promega, Turner Biosystems, Madi-
son, WI, USA). Firefly luciferase activity was normalized
to Renilla luciferase activity to adjust for variations in
transfection efficiency among experiments. Data were
also normalized to the impact of each miRNA on the lu-
ciferase mRNA without NFL 3′UTR to obtain the spe-
cific effect on the NFL mRNA 3′UTR. All experiments
were performed in triplicate. Quantitative data of the re-
porter gene assay are presented as mean ± SEM. The
Student’s t-test was used to determine significant differ-
ences between two groups.Relative quantitative RT-PCR
24 h after transfection total RNA was isolated using TRIzol
reagent (Life Technologies Inc., Ambion) according to the
manufacturer’s instructions. After the reverse transcription,
relative quantitative PCR was carried out co-amplifying
Firefly and Renilla luciferases encoded in the same
pmirGLO vector using the following primers: fLuc: forward
5′ CAA GAC TATAAG ATT CAATCT GCC CTG CTG
3′ and reverse 5′ GAT GTT GGG GTG TTG CAG CAG
GAT 3′; rLuc: forward 5′ GAG CAA CGC AAA CGC
ATG ATC ACT G 3′ and reverse 5′ TTC AGC AGC
TCG AAC CAA GCG GT 3′.
The intensity of the bands from the agarose gel was
quantified by densitometry. Firefly luciferase densitom-
etry was normalized to Renilla luciferase densitometry to
adjust for variations in transfection efficiency among ex-
periments. Data were also normalized to the impact of
each miRNA on the luciferase mRNA without NFL 3′
UTR and to the effect of miR-let-7a (miRNA control) on
the luciferase mRNA to obtain the specific effect on the
NFL mRNA 3′UTR. All experiments were performed in
triplicate. The Student’s t-test was used to determine sig-
nificant differences between two groups.Additional file
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